Filtered By:
Condition: Addiction

This page shows you your search results in order of date.

Order by Relevance | Date

Total 121 results found since Jan 2013.

FDA Updating Warnings to Improve Safe Use of Prescription Stimulants Used to Treat ADHD and Other Conditions.
The FDA is requiring updates to the Boxed Warning and other information to ensure the prescribing information is made consistent across the entire class of these medicines to address continuing concerns of misuse, abuse, addiction, and overdose of prescription stimulants.
Source: FDA Center for Drug Evaluation and Research - What's New - May 26, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA Moves to Curb Misuse of ADHD Meds FDA Moves to Curb Misuse of ADHD Meds
The FDA has announced updates to ADHD stimulant medication labels to note the serious risks of misuse, abuse, addiction, and the sharing of these drugs.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - May 12, 2023 Category: Neurology Tags: Psychiatry News Source Type: news

Opioid Settlement Hinders Patients ’ Access to ADHD Medication and Other Drugs
An agreement between attorneys general and major drug distributors increased scrutiny on medications for A.D.H.D., addiction, anxiety and pain.
Source: NYT Health - March 13, 2023 Category: Consumer Health News Authors: Christina Jewett and Ellen Gabler Tags: Drugs (Pharmaceuticals) Drugstores Opioids and Opiates Suits and Litigation (Civil) Shortages AmerisourceBergen Corp Cardinal Health Inc McKesson Corporation Pain-Relieving Drugs Adderall (Drug) Source Type: news

How an Opioid Settlement Hinders Patients ’ Access to ADHD Medication and Other Drugs
An agreement between attorneys general and major drug distributors increased scrutiny on medications for A.D.H.D., addiction, anxiety and pain.
Source: NYT Health - March 13, 2023 Category: Consumer Health News Authors: Christina Jewett and Ellen Gabler Tags: Drugs (Pharmaceuticals) Drugstores Opioids and Opiates Suits and Litigation (Civil) Shortages Source Type: news

How the pandemic fueled America's Adderall addiction: One in EIGHT people are on ADHD prescription
Some 41million Americans are currently using the drug, estimates suggest, a surge of 16 percent from before the pandemic. Telemedicine companies have driven the rise.
Source: the Mail online | Health - January 4, 2023 Category: Consumer Health News Source Type: news

ADHD Medication Might Help In Treating Amphetamine Addiction
A recent JAMA Psychiatry study found that an ADHD medicine called lisdexamfetamine reduced the risk of hospitalization due to amphetamine or methamphetamine addiciton by 18% and 14% for deaths caused by substance abuse disorders.
Source: Forbes.com Healthcare News - November 25, 2022 Category: Pharmaceuticals Authors: Anuradha Varanasi, Contributor Tags: Healthcare /healthcare Innovation /innovation Source Type: news

The Online Therapy Bubble Is Bursting
Hebah Arroyo, an Illinois nurse practitioner, began working for the startup Done in the spring of 2020. She was drawn to the San Francisco-based company’s promise: to provide stigma-free online ADHD care, including prescription refills and virtual sessions with clinicians, for as little as $79 a month. “It was my first telehealth role,” she says, “so that was exciting for me.” Three months later, she resigned. “I quickly became unhappy because there was not any support for the clinicians” and the quality of care was lacking, Arroyo says. She regularly saw four patients an hour, a g...
Source: TIME: Health - November 1, 2022 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized feature healthscienceclimate Mental Health Source Type: news

Smoking during pregnancy may not cause ADHD in children after all
A new systematic review and meta-analysis published in the scientific journal Addiction and led by University of Bristol researchers shows that maternal prenatal smoking is associated with offspring attention-deficit hyperactivity disorder (ADHD) but is unlikely to be the cause of it.
Source: University of Bristol news - April 7, 2022 Category: Universities & Medical Training Tags: Health, Research; Faculty of Life Sciences, School of Psychological Science, Faculty of Life Sciences; Press Release Source Type: news

ADHD Meds May Boost Treatment Retention in Comorbid Addiction ADHD Meds May Boost Treatment Retention in Comorbid Addiction
Judicious use of stimulants may help patients with ADHD and comorbid substance use disorder stay in addiction treatment programs, new research shows.Medscape Medical News
Source: Medscape Internal Medicine Headlines - December 15, 2020 Category: Internal Medicine Tags: Psychiatry News Source Type: news

Why doctors may start prescribing nicotine to help beat disease
Nicotine - the main addictive element of cigarettes - is emerging in studies as a promising treatment for Parkinson's, ADHD, dementia, schizophrenia and even coronavirus.
Source: the Mail online | Health - October 20, 2020 Category: Consumer Health News Source Type: news

The Coronavirus Seems to Spare Most Kids From Illness, but Its Effect on Their Mental Health Is Deepening
Pandemics can be indiscriminate, with viruses making no distinctions among the victims they attack and those they spare. If you’re human, you’ll do. COVID-19 has been different, particularly when it comes to age. The disease has shown a special animus for older people, with those 65-plus considered at especially high risk for hospitalization and death, and those 18 and below catching a semblance of an epidemiological break. Though a small share of adolescents have suffered severe cases, most who contract the disease in that age cohort are likelier to experience milder symptoms or none at all. But if COVID-19 is...
Source: TIME: Health - July 23, 2020 Category: Consumer Health News Authors: Jeffrey Kluger Tags: Uncategorized COVID-19 feature Magazine Source Type: news

Study: Doctor payments from pharma coincide with more ADHD prescriptions
Researchers have shown clear connections between the opioid epidemic and increase of pharmaceutical company payments to doctors. Now, new research shows a similar phenomenon with prescribing stimulants to children with attention deficit hyperactivity disorder. A study published by researchers at Boston Medical Center’s Grayken Center for Addiction in JAMA Pediatrics, found that stimulant drug manufacturers are interacting with doctors frequently. From 2014 to 2018, the industry offered food or…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 27, 2020 Category: Pharmaceuticals Authors: Jessica Bartlett Source Type: news

Young Adults With ADHD More Vulnerable to Nicotine
MONDAY, Dec. 16, 2019 -- Young adults with attention-deficit/hyperactivity disorder (ADHD) are at increased risk for nicotine addiction, new research shows. For the study, a Duke University team used a nasal spray to determine how nicotine affected...
Source: Drugs.com - Daily MedNews - December 16, 2019 Category: General Medicine Source Type: news

Cannabis has great medical potential. But don ’t fall for the CBD scam | Mike Power
The UK market for cannabidiol, a compound found in cannabis, will soon be worth £1bn. But consumers are being connedRoll up, roll up, ladies and gentleman, and gather around. Do you, your loved one – or family pet – suffer from any of the following conditions? Cancer, epilepsy, diabetes, arthritis, anxiety, menstrual cramps, insomnia, dry skin, psychosis, Alzheimer’s, dementia, anger, depression, ADHD, Crohn’s and IBS, PTSD, opiate addiction, Parkinson’s, pain of any kind, migraine, or canine uptightness? Then it’s your lucky day.Related:CBD: a marijuana miracle or just another health fad?Continue reading...
Source: Guardian Unlimited Science - July 1, 2019 Category: Science Authors: Mike Power Tags: Cannabis Drugs Society Health Medicine Science Pharmaceuticals industry Business Source Type: news

Medical News Today: What are the side effects and risks of Ritalin?
Ritalin (methylphenidate) is a stimulant medication for the treatment of ADHD and narcolepsy. Ritalin can cause side effects and has the potential for misuse and addiction. Researchers are investigating the long-term safety and effectiveness of this drug in children and adolescents. Learn more here.
Source: Health News from Medical News Today - May 31, 2019 Category: Consumer Health News Tags: ADHD / ADD Source Type: news